You are here: Industry Insights > cell and gene therapy

News List

Paragon Biosciences Expands Cell and Gene Therapy Platform contractpharma
February 09, 2021
Paragon Biosciences, a life science innovator that creates, invests in and builds life science companies in biopharmaceuticals, cell and gene therapy and synthetic biology utilizing artificial intelligence, has launched CiRC Biosciences ...
Cognate BioServices, Nucleus Biologics Form Cell & Gene Therapy Partnership contractpharma
February 01, 2021
Cognate BioServices, a global contract development and manufacturing organization (CDMO) in the cell and gene therapy industry, and Nucleus Biologics, have formed a partnership for custom and commercial medias and delivery systems for cell and gene ...
UK biotech Ixaka scores additional funding for cell and gene therapy research pharmatimes
January 19, 2021
London, UK-based integrated cell and gene therapy company Ixaka – formerly Rexgenero – has launched with additional financing from existing shareholders totalling over £40m.
Cognate BioServices Announces Major Expansion contractpharma
January 19, 2021
Cognate BioServices Inc. has announced plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase office support at its facilities in the United States and Europe.
Bayer transforms pharma business through breakthrough innovation in healthcare worldpharmanews
January 18, 2021
At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are currently still ...
Precision Medicine Group Acquires Project Farma contractpharma
January 15, 2021
Precision Medicine Group (PMG) has acquired Project Farma, a bioengineering services firm that supports the manufacture and scale-up of advanced therapies.
Bayer establishes new cell and gene therapy platform pharmatimes
December 04, 2020
Bayer has launched a Cell and Gene Therapy (C>) Platform, aiming to accelerate its presence in this area.
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition prnasia
October 29, 2020
After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. on September 30, 2020, AGC Biologics announced that MolMed's entity name has been changed to AGC Biologics S.p.A.
Bayer acquires gene therapy specialist AskBio for $4bn pharmaceutical-technology
October 28, 2020
Bayer has announced the acquisition of US-headquartered cell and gene therapy specialist Asklepios BioPharmaceutical (AskBio) in a deal worth $4bn.
CellGenix Expands Facility contractpharma
October 15, 2020
CellGenix GmbH, a global supplier of raw and ancillary materials for cell and gene therapies, has completed the second phase of its facility expansion.

Previous page 1 2 3 4 5 Next page